Vascular lipidomics analysis reveales increased levels of phosphocholine and lysophosphocholine in atherosclerotic mice

[1]  R. Giugliano,et al.  Lipoprotein(a) and its Significance in Cardiovascular Disease: A Review. , 2022, JAMA cardiology.

[2]  J. Björkegren,et al.  Atherosclerosis: Recent developments , 2022, Cell.

[3]  S. Louie,et al.  Lipidomics in Understanding Pathophysiology and Pharmacologic Effects in Inflammatory Diseases: Considerations for Drug Development , 2022, Metabolites.

[4]  Xiaoran Zhang,et al.  Prediction model for different progressions of Atherosclerosis in ApoE-/- mice based on lipidomics. , 2022, Journal of pharmaceutical and biomedical analysis.

[5]  R. Gross,et al.  The foundations and development of lipidomics , 2021, Journal of lipid research.

[6]  Nicholas D. Camarda,et al.  Systems Approach to Integrating Preclinical Apolipoprotein E-Knockout Investigations Reveals Novel Etiologic Pathways and Master Atherosclerosis Network in Humans , 2021, Arteriosclerosis, thrombosis, and vascular biology.

[7]  A. Scholte,et al.  A specific plasma lipid signature associated with high triglycerides and low HDL cholesterol identifies residual CAD risk in patients with chronic coronary syndrome. , 2021, Atherosclerosis.

[8]  M. Shapiro,et al.  Apolipoproteins in vascular biology and atherosclerotic disease , 2021, Nature Reviews Cardiology.

[9]  Ming Yang,et al.  Study on the new anti-atherosclerosis activity of different Herba patriniae through down-regulating lysophosphatidylcholine of the glycerophospholipid metabolism pathway. , 2021, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[10]  V. Fuster,et al.  Triglycerides and Residual Atherosclerotic Risk , 2021, Journal of the American College of Cardiology.

[11]  G. Norata,et al.  Global epidemiology of dyslipidaemias , 2021, Nature Reviews Cardiology.

[12]  C. Field,et al.  Dietary phosphatidylcholine supplementation reduces atherosclerosis in Ldlr-/- male mice2. , 2021, The Journal of nutritional biochemistry.

[13]  Jia Liu,et al.  Serum metabolomic patterns in young patients with ischemic stroke: a case study , 2021, Metabolomics.

[14]  M. Cuchel,et al.  Controversial Role of Lecithin:Cholesterol Acyltransferase in the Development of Atherosclerosis: New Insights From an LCAT Activator. , 2021, Arteriosclerosis, thrombosis, and vascular biology.

[15]  OUP accepted manuscript , 2021, Nucleic Acids Research.

[16]  K. Thalassinos,et al.  Developments in tandem ion mobility mass spectrometry , 2020, Biochemical Society transactions.

[17]  Q. Dai,et al.  Targeting HDAC6 attenuates nicotine-induced macrophage pyroptosis via NF-κB/NLRP3 pathway. , 2020, Atherosclerosis.

[18]  Kipp W. Johnson,et al.  Molecular Imaging of Apoptosis in Atherosclerosis by Targeting Cell Membrane Phospholipid Asymmetry. , 2020, Journal of the American College of Cardiology.

[19]  B. Kwon,et al.  Development of a NanoLC-MS workflow for high-sensitivity global lipidomic analysis. , 2020, Analytica chimica acta.

[20]  Jing Zhang,et al.  Plasma lipidomic analysis of sphingolipids in patients with large artery atherosclerosis cerebrovascular disease and cerebral small vessel disease , 2020, Bioscience reports.

[21]  T. Alexandrov.  Spatial Metabolomics and Imaging Mass Spectrometry in the Age of Artificial Intelligence. , 2020, Annual review of biomedical data science.

[22]  Yuyu Sun,et al.  Ingenuity pathway analysis of human facet joint tissues: Insight into facet joint osteoarthritis , 2020, Experimental and therapeutic medicine.

[23]  Jun Yu Li,et al.  Salidroside Decreases Atherosclerosis Plaque Formation via Inhibiting Endothelial Cell Pyroptosis , 2020, Inflammation.

[24]  Xiang Chen,et al.  The mechanisms of lysophosphatidylcholine in the development of diseases. , 2020, Life sciences.

[25]  R. Kaliszan,et al.  Metabolomic Signature of Early Vascular Aging (EVA) in Hypertension , 2020, Frontiers in Molecular Biosciences.

[26]  C. Mineo.  Lipoprotein Receptor Signaling in Atherosclerosis. , 2019, Cardiovascular research.

[27]  P. Hains,et al.  A Barocycler-based Concurrent Multi-Omics Method to Assess Molecular Changes Associated with Atherosclerosis using Small Amounts of Arterial Tissue from a Single Mouse. , 2019, Analytical chemistry.

[28]  P. Libby,et al.  Atherosclerosis , 2019, Nature Reviews Disease Primers.

[29]  D. Repsilber,et al.  Serum untargeted lipidomic profiling reveals dysfunction of phospholipid metabolism in subclinical coronary artery disease , 2019, Vascular health and risk management.

[30]  P. Escribá,et al.  Membrane Lipid Composition: Effect on Membrane and Organelle Structure, Function and Compartmentalization and Therapeutic Avenues , 2019, International journal of molecular sciences.

[31]  P. Libby,et al.  Inflammation: a common contributor to cancer, aging, and cardiovascular diseases—expanding the concept of cardio-oncology , 2019, Cardiovascular research.

[32]  D. Gauguier,et al.  Untargeted Mass Spectrometry Lipidomics identifies correlation between serum sphingomyelins and plasma cholesterol , 2019, Lipids in Health and Disease.

[33]  Xin Li,et al.  Spatially resolved metabolomics to discover tumor-associated metabolic alterations , 2018, Proceedings of the National Academy of Sciences.

[34]  G. Werstuck,et al.  Glycosphingolipids promote pro-atherogenic pathways in the pathogenesis of hyperglycemia-induced accelerated atherosclerosis , 2018, Metabolomics.

[35]  C. McMaster.  From yeast to humans – roles of the Kennedy pathway for phosphatidylcholine synthesis , 2018, FEBS letters.

[36]  R. Krauss,et al.  Low-density lipoproteins cause atherosclerotic cardiovascular disease , 2018 .

[37]  Lale Tokgözoğlu,et al.  Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel , 2017, European heart journal.

[38]  A. Orekhov,et al.  Macrophages and Their Contribution to the Development of Atherosclerosis. , 2017, Results and problems in cell differentiation.

[39]  P. Libby,et al.  Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis , 2016 .

[40]  S. Furse,et al.  Phosphatidylcholine’s functions beyond that of a membrane brick , 2015, Molecular membrane biology.

[41]  N. Ridgway.  The role of phosphatidylcholine and choline metabolites to cell proliferation and survival , 2013, Critical reviews in biochemistry and molecular biology.

[42]  P. Vandenabeele,et al.  Cell surface-expressed phosphatidylserine as therapeutic target to enhance phagocytosis of apoptotic cells , 2012, Cell Death and Differentiation.

[43]  J. Adamski,et al.  Evidence Supporting a Key Role of Lp-PLA2-Generated Lysophosphatidylcholine in Human Atherosclerotic Plaque Inflammation , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[44]  V. Dolinsky,et al.  Impaired Phosphatidylcholine Biosynthesis Reduces Atherosclerosis and Prevents Lipotoxic Cardiac Dysfunction in ApoE−/− Mice , 2011, Circulation research.

[45]  G. Schmitz,et al.  Metabolism and atherogenic disease association of lysophosphatidylcholine. , 2010, Atherosclerosis.

[46]  O. Simonetti,et al.  Gadolinium-containing phosphatidylserine liposomes for molecular imaging of atherosclerosis , 2009, Journal of Lipid Research.

[47]  F. Meyer,et al.  Enhanced Expression of Lp-PLA2 and Lysophosphatidylcholine in Symptomatic Carotid Atherosclerotic Plaques , 2008, Stroke.

[48]  G. Meer,et al.  Membrane lipids: where they are and how they behave , 2008, Nature Reviews Molecular Cell Biology.

[49]  N. Aiyar,et al.  Lysophosphatidylcholine induces inflammatory activation of human coronary artery smooth muscle cells , 2006, Molecular and Cellular Biochemistry.

[50]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[51]  Xianlin Han,et al.  Electrospray ionization mass spectroscopic analysis of human erythrocyte plasma membrane phospholipids. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[52]  R. Sundler,et al.  Biosynthesis of phosphatidylethanolamines and phosphatidylcholines from ethanolamine and choline in rat liver. , 1975, The Biochemical journal.

[53]  E. P. Kennedy,et al.  The function of cytidine coenzymes in the biosynthesis of phospholipides. , 1956, The Journal of biological chemistry.